Revisiting Wilms tumour surveillance in Beckwith–Wiedemann syndrome with IC2 methylation loss, reply-Reference-Cited by-同舟云学术

Revisiting Wilms tumour surveillance in Beckwith–Wiedemann syndrome with IC2 methylation loss, reply

Published:2018-02-15 Issue:4 Volume:26 Page:471-472
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Brioude Frédéric^ORCID,Hennekam Raoul,Bliek Jet,Coze Carole,Eggermann Thomas,Ferrero Giovanni B.,Kratz Christian,Bouc Yves Le,Maas Saskia M.,Mackay Deborah J. G.,Maher Eamonn R.,Mussa Alessandro,Netchine Irene

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/s41431-017-0074-2.pdf

Reference7 articles.

1. Brzezinski J, Shuman C, Choufani S, et al. Wilms tumour in Beckwith-Wiedemann syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines. Eur J Hum Genet. 2017. https://doi.org/10.1038/ejhg.2017.

2. Maas SM, Vansenne F, Kadouch DJ, et al. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on the molecular genetic subgroups. Am J Med Genet Part A. 2016;170:2248–60.

3. Brioude F, Kalish JM, Mussa A, et al. Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol. 2018 Jan 29. doi: 10.1038/nrendo.2017.166.

4. Keren B, Chantot-Bastaraud S, Brioude F, et al. SNP arrays in Beckwith-Wiedemann syndrome: an improved diagnostic strategy. Eur J Med Genet. 2013;56:546–50.

5. Mussa A, Peruzzi L, Chiesa N, et al. Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome. Pediatr Nephrol. 2012;27:397–406.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic approaches to imprinting diseases;Epigenetics in Human Disease;2024

2. Clinical Spectrum and Tumour Risk Analysis in Patients with Beckwith-Wiedemann Syndrome Due to CDKN1C Pathogenic Variants;Cancers;2022-08-05

3. Molecular Basis of Beckwith–Wiedemann Syndrome Spectrum with Associated Tumors and Consequences for Clinical Practice;Cancers;2022-06-23

4. Epimutation in inherited metabolic disorders: the influence of aberrant transcription in adjacent genes;Human Genetics;2022-02-21

5. Characteristics Associated with Tumor Development in Individuals Diagnosed with Beckwith–Wiedemann Spectrum: Novel Tumor-(epi)Genotype-Phenotype Associations in the BWSp Population;Genes;2021-11-21